Early prodromal symptoms can predict future psychosis in familial high-risk youth

Journal of Psychiatric Research

Volumn 46, Issue 1, 2012, Pages 105-110

  Tandon, Neeraj ^a   Montrose, Debra ^b   Shah, Jai ^a   Rajarethinam, R P ^c   Diwadkar, Vaibhav A ^c   Keshavan, Matcheri S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

Familial; High risk; Prediction; Prevention; Prodrome; Psychosis; Schizophrenia; Schizotypy

Indexed keywords

ADOLESCENT; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SENSITIVITY AND SPECIFICITY; SOCIAL STATUS; STRUCTURED INTERVIEW;

EID: 81855207425     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.09.019     Document Type: Article

References (52)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders 2000, DSM-IV-TR, American Psychiatric Association, Washington, DC, American Psychiatric Association, 2011. DSM-5 Progress. http://www.dsm5.org, Revised 4th ed.
2. Bhojraj T.S., Sweeney J.A., Prasad K.M., Eack S.M., Francis A.N., Miewald J.M., et al. Gray matter loss in young relatives at risk for schizophrenia: Relation with prodromal symptomatology. Neuroimage 2011, 54(Suppl 1):S272-S279.
3. Bhojraj T.S., Diwadkar V.A., Sweeney J.A., Prasad K.M., Eack S.M., Montrose D.M., et al. Longitudinal alterations of executive function in non-psychotic adolescents at familial risk for schizophrenia. Progress in Neuropsychopharmacology and Biology Psychiatry 2011, 34:469-474.
4. Bruijnzeel D., Tandon R. The concept of schizophrenia: from the 1850s to the DSM-5. Psychiatric Annals 2011, 41:289-295.
5. Cannon T.D., Cadenhead K., Cornblatt B., Woods S.W., Addington J., Walker E., et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry 2008, 65:28-37.
6. Carpenter W.T. Anticipating DSM-V: should psychosis risk become a diagnostic class?. Schizophrenia Bulletin 2009, 35:841-843.
7. Chapman L.J., Chapman J.P., Raulin M.L. Body image aberration in schizophrenia. Journal of Abnormal Psychology 1978, 87:399-407.
8. Corcoran C.M., Kimhy D., Stanford A., Khan S., Walsh J., Thompson J., et al. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis. Schizophrenia Research 2008, 106:286-293.
9. Corcoran C.M., First M.B., Cornblatt B. The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis. Schizophr Res 2010, 120:16-22.
10. Correll C.U., Hauser M., Auther A.M., Cornblatt B.A. Research in people with psychosis risk syndrome: a review of the current evidence and future directions. Journal of Child Psychology and Psychiatry 2010, 51:390-431.
11. Dragt S., Nieman D.H., Veltman D., Becker H.E., van de Fliert R., de Haan L., et al. Environmental factors and social adjustment as predictors of a first psychosis in subjects at ultra high risk. Schizophrenia Research.125 2011, 69-76.
12. Drake R.J., Lewis S.W. Valuing prodromal psychosis: what do we get and what is the price?. Schizophrenia Research 2010, 120:38-41.
13. Fusar-Poli P., Byrne M., Valmaggia L., Day F., Tabraham P., Johns L., et al. Social dysfunction predicts two years clinical outcome in people at ultra high risk for psychosis. Journal of Psychiatric Research 2010, 44:294-301.
14. Genetic Risk and Outcome in Psychosis (GROUP) Investigators Evidence that familial liability for psychosis is expressed as differential sensitivity to cannabis. Archives of General Psychiatry 2011, 68:138-147.
15. Grootenboer E.M., Giltay E.J., van der Lem R., van Veen T., van der Wee N.J., Zitman F.G. Reliability and validity of the global assessment of functioning scale in clinical outpatients with depressive disorders. Journal of Evaluation in Clinical Practice 2011 Jan 11, [Epub ahead of print] PubMed PMID: 21223457. 10.1111/j.1365-2753.2010.01614.x.
16. Harrison G., Hopper K., Craig T., Laska E., Siegel C., Wanderling J., et al. Recovery from psychotic illness: a 15- and 25- year international follow-up study. British Journal of Psychiatry 2001, 178:506-517.
17. Johnstone E.C., Ebmeier K.P., Miller P., Owens D.G.C., Lawrie S.M. Predicting schizophrenia: findings from the Edinburgh high-risk study. British Journal of Psychiatry 2005, 6:18-25.
18. Keshavan M.S., DeLisi L.E., Seidman L.J. Early and broadly defined psychosis risk states. Schizophrenia Research 2011, 126:1-10.
19. Koutseleris N., Meisenzahl E.M., Davatzikos C., Bottlender R., Frodl T., Scheuerecker J., et al. Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Archives of General Psychiatry 2009, 66:700-712.
20. Kwapil T.R., Barrantes-Vidal N., Silvia P.J. The dimensional structure of the Wisconsin Schizotypy scales: factor identification and construct validity. Schizophrenia Bulletin 2008, 34:444-457.
21. Lawrie S.M., McIntosh A.M., Hall J., Owens D.G.C., Johnstone E.C. Brain structure and function changes during the development of schizophrenia: The evidence from studies of subjects at increased genetic risk. Schizophrenia Bulletin 2008, 4:330-340.
22. Lee C., McGlashan T.M., Woods S.W. Prevention of schizophrenia: can it be achieved?. CNS Drugs 2005, 19:193-206.
23. Lenzenweger M.F. Psychometric high-risk paradigm, perceptual aberrations, and schizotypy: an update. Schizophrenia Bulletin 1994, 20:121-135.
24. Liu P., Parker A.G., Hetrick S.E., Callahan P., de Silva S., Purcell R. An evidence map of interventions across premorbid, ultra high-risk, and first episode phases of psychosis. Schizophrenia Research 2010, 3:37-44.
25. McGorry P.D. Back to the future. Predicting and reshaping the course of psychotic disorder. Archives of General Psychiatry 2008, 65:25-27.
26. McGorry P.D., Nelson B., Amminger G.P., et al. Intervention in individuals at ultra-high risk for psychosis: a review and future directions. J Clin Psychiatry 2009, 70:1206-1212.
27. McGorry P.D. Risk syndromes, clinical staging and DSM-V: new diagnostic infrastructure for early intervention in psychiatry. Schizophrenia Research 2010, 120:49-53.
28. McIntosh A.M., Owens D.G.C., Moorhead W.J., Whalley H.C., Stanfield A.C., Hall J., et al. Longitudinal volume reductions in people at high genetic risk of schizophrenia as they develop psychosis. Biological Psychiatry 2011, 69:953-958.
29. Miller T.J., McGlashan T.H., Rosen J.L. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of inter-rater reliability and predictive validity. American Journal of Psychiatry 2002, 159:863-865.
30. National Research Council and Institute of Medicine Preventing mental, emotional, and behavioral disorders among young people: progress and possibilities 2009, National Acadamies Press, Washington, D.C.
31. Nelson B., Yuen K., Yung A.R. Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?. Schizophrenia Research 2011, 125:62-68.
32. Newman Thomas B., Warren Browner S., Cummings Steven R. Chapter 12-Designing studies of medical tests. Designing clinical research 2001, 175-193. Lippincott Williams & Wilkins, Philadelphia, PA.
33. Preti A., Cella M. Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophrenia Research 2010, 123:30-36.
34. Ruhrmann S., Schultze-Lutter F., Klosterkotter J. Intervention in the at-risk state to prevent transition to psychosis. Current Opinion in Psychiatry 2009, 22:177-183.
35. Ruhrmann S., Schultze-Lutter F., Salakongas R.K.R., Heinimaa M., Linszen D., Dingemans P., et al. Prediction of psychosis in adolescents and young adults at high risk: results from the European prediction of psychosis study. Archives of General Psychiatry 2010, 67:241-251.
36. Ruhrmann S., Schultze-Lutter F., Klosterkotter J. Probably at-risk but certainly ill - advocating the introduction of a psychosis spectrum disorder in DSM-V. Schizophrenia Research 2010, 120:23-27.
37. Sackett D.L., Strauss S.E., Richardson W.S., Rosenberg W., Haynes R.B., et al. Evidence-based medicine: How to practice and teach EBM. 2000, Churchill Livingstone, Edinburgh.
38. Schlosser D.A., Zinberg J.L., Loewy R.L., Casey-Cannon S., O'Brien M.P., Bearden C.E., et al. Predicting the longitudinal effects of the family environment on prodromal symptoms and functioning in patients at-risk for psychosis. Schizophrenia Research 2010, 118:69-75.
39. Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, Li G, et al., 2011. Recovery from at-risk state. Schizophrenia Bulletin.
40. Smieskova R., Fusar-Poli P., Allen P., Bendfeldt K., Stieglitz R.D., Drewe J., et al. Neuroimaging predictors of transition to psychosis- A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews 2010, 34:1207-1222.
41. Spitzer R.L., Williams J.B., Gibbons M., First M.B. The structured clinical interview for DSM (SCID). 1. History, rationale, and description. Archives of General Psychiatry 1992, 49:624-629.
42. Sun D., Phillips L., Velakoulis D., Yung A., McGorry P.D., Wood S.J., et al. Progressive brain structural changes mapped as psychosis develops in 'at risk' individuals. Schizophrenia Research 2009, 108:85-92.
43. Takahashi T., Wood S.J., Yung A.R., Soulsby B., McGorry P.D., Suzuki M., et al. Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis. Archives of General Psychiatry 2009, 66:366-376.
44. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophrenia Research 2009, 110:1-23.
45. Tandon R., Nasrallah H.A., Keshavan M.S. Schizophrenia, "just the facts" 5. Treatment and prevention. Schizophrenia Research 2010, 122:1-23.
46. Thompson, A., Nelson, B., Yung, A. Predictive validity of clinical variables in the "at risk" for psychosis population: international comparison with results from the North American Prodrome Longitudinal Study. Schizophrenia Research in press.
47. Welch KA, McIntosh AM, Job DE, Whalley HC, Moorhead TW, Hall J, et al., 2011. The impact of substance abuse on brain structure in people at high risk of developing schizophrenia. Schizophrenia Bulletin.
48. Woods S.W., Addington J., Cadenhead K.S., Cannon T.D., Cornblatt B.A., Heinssen R., et al. Validity of the prodromal risk syndrome for first psychosis: Findings from the North American Prodrome Longitudinal Study. Schizophrenia Bulletin 2009, 35:894-908.
49. Woods S.W., Walsh B.C., Saksa J.R., McGlashan T.H. The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome. Schizophrenia Research 2010, 123:199-207.
50. Yung A.R., Phillips L.J., McGorry P.D., McFarlane C.A., Francey S., Harrigan S., et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. British Journal of Psychiatry Supplement 1998, 172(33):14-20.
51. Yung A.R., Nelson B., Stanford C., Simmons M.B., Cosgrave E.M., Killackey E., et al. Validation of ' prodromal' criteria to detect individuals at ultra-high risk of psychosis: 2 year follow-up. Schizophrenia Research 2008, 105:10-17.
52. Yung A.R., Nelson B., Thompson A.D., Wood S.J. Should a "risk syndrome for psychosis" be included in the DSM-V?. Schizophrenia Research 2010, 120:7-15.